Efficacy of human papillomavirus vaccines: a systematic quantitative review
LR Medeiros, DD Rosa, MI Da Rosa… - International Journal of …, 2009 - ijgc.bmj.com
Human papillomavirus (HPV) types cause approximately 70% of cervical cancer worldwide.
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …
[HTML][HTML] Efficacy of human papillomavirus vaccines: a systematic quantitative review
LR Medeiros, DD Rosa, MI da Rosa… - Database of Abstracts …, 2009 - ncbi.nlm.nih.gov
This review concluded that prophylactic vaccination can prevent infection with human
papillomavirus (HPV) in women (nine to 26 years) who had not previously been infected …
papillomavirus (HPV) in women (nine to 26 years) who had not previously been infected …
Efficacy of Human Papillomavirus Vaccines: A Systematic Quantitative Review
LR Medeiros, DD Rosa, MI Da Rosa… - International …, 2009 - search.proquest.com
Human papillomavirus (HPV) types cause approximately 70% of cervical cancer worldwide.
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …
Efficacy of human papillomavirus vaccines: a systematic quantitative review.
LR Medeiros, DD Rosa, MI da Rosa… - … : Official Journal of the …, 2009 - europepmc.org
Human papillomavirus (HPV) types cause approximately 70% of cervical cancer worldwide.
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …
[PDF][PDF] Efficacy of human papillomavirus vaccines: a systematic quantitative review
LR Medeiros, DD Rosa, MI da Rosa, MC Bozzetti… - 2017 - academia.edu
This review concluded that prophylactic vaccination can prevent infection with human
papillomavirus (HPV) in women (nine to 26 years) who had not previously been infected …
papillomavirus (HPV) in women (nine to 26 years) who had not previously been infected …
Efficacy of human papillomavirus vaccines: a systematic quantitative review
LR Medeiros, DD Rosa, MI da Rosa… - … : official journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Human papillomavirus (HPV) types cause approximately 70% of cervical cancer worldwide.
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …